ITGAM and neoplasm: We did not find any significant variations in the total percentage of CD11b+ cells (around 30% of intra-tumoral MDSCs on total tumor cells) but we observed a significant reduction in the percentage of PMN-MDSCs (Ly6G+) and macrophages (Ly6C-/Ly6G-/F4/80+) in mice MCA203-W30L-bearing mice compared to the MCA203-GM controls (Figure 2C and Supplementary Figure 5A).